Early Management of Onabotulinumtoxina Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
media
posted on 2021-03-23, 10:40 authored by Raffaele Ornello, Fayyaz Ahmed, Andrea Negro, Anna Maria Miscio, Antonio Santoro, Alicia Alpuente, Antonio Russo, Marcello Silvestro, Sabina Cevoli, Nicoletta Brunelli, Fabrizio Vernieri, Licia Grazzi, Carlo Baraldi, Simona Guerzoni, Anna P. Andreou, Giorgio Lambru, Ilaria Frattale, Katharina Kamm, Ruth Ruscheweyh, Marco Russo, Paola Torelli, Elena Filatova, Nina Latysheva, Anna Gryglas-Dworak, Marcin Straburzynski, Calogera Butera, Bruno Colombo, Massimo Filippi, Patricia Pozo-Rosich, Paolo Martelletti, Simona Sacco<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
History
Related Materials
- 1.
- 2.
